In addition to the effects on cell migration and invasion, we believe our identification of the downstream pathways of HK2—Namely the HK2 to FAK to MEK-1/ERK1/2 pathway that controls NANOG and SOX9 expression and ovarian cancer CSC properties—Will be of significant importance to future studies. The gene discussed is NANOG; the disease is ovarian cancer.